UK CMO APPOINTS NEW DIRECTOR

STERILE manufacturing specialist Symbiosis Pharmaceutical Services has appointed Joanne Anderson as its new Business Development Director to help drive its commercial growth.The company has promoted Mrs Anderson to the role following three successful years with the Scotland-based pharmaceutical contract manufacturing organisation (CMO) and will join the management team.Reporting to the CEO, her responsibilities will include the strategic and operational management of all… Read More

Successful sterile inspection for Scottish CMO

Stirling, UK – INJECTABLE manufacturing specialist Symbiosis Pharmaceutical Services has successfully completed a scheduled inspection from the UK Government Regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).The contract manufacturing organisation (CMO) received no critical or major observations and this comes amidst various quality-related issues affecting several other sterile manufacturing sites in the UK and US.Symbiosis has been re-inspected and approved for… Read More

CMO in bulk lyophilisation launch

Stirling, UK – STERILE manufacturing specialist Symbiosis Pharmaceutical Services has unveiled a new bulk lyophilisation (freeze drying) service after winning several new contracts in this niche area.The Scotland-based contract manufacturing organisation (CMO) is supporting clients in the US, Europe and Asia to assist with the manufacture of bulk intermediates and APIs by lyophilisation.Although the company has been providing lyophilisation for the sterile… Read More

Symbiosis boosts US presence in response to market growth

UK-based sterile filling specialist Symbiosis Pharmaceutical Services has strengthened its North American footprint with the appointment of a US-based business development manager to support increased demand from biotech companies for its manufacturing services.The move to reinforce Symbiosis’ presence in North America is bolstered by the recent surge in funding of biotech firms in the US. A more positive investor climate in the US continues to… Read More

Au revoir CPhI Paris

From the 7th until the 10th October the Symbiosis team attended CPhI, one of Europe’s largest pharmaceutical conferences held in Paris, France. Our two European Business Development Managers and our CEO were in attendance at the event with support from our friends at Scottish Development International. Thanks to those of you who visited our stand, especially given the challenges of navigating the… Read More

Symbiosis to attend CPhI

Symbiosis will be returning for the third consecutive year to exhibit at the CPhI conference to promote our world class sterile manufacturing capabilities with support from our friends from Scottish Development International. The event held at Nord Villepinte, Paris, France, from the 7th to 9th October is one of the world’s leading pharmaceutical events. It provides an exciting opportunity for Symbiosis to… Read More

Symbiosis to attend Biotech Outsourcing Strategies cmc

Symbiosis, a leading cGMP manufacturer of sterile pharmaceuticals for clinical trials, is looking forward to attending a key event in the drug development outsourcing calendar later this month.  We will be attending Biotech Outsourcing Strategies (BOS) cmc on the 12th June in Copenhagen, Denmark.With a programme including small molecule and biologics tracks and a strong emphasis on virtual drug development, BOS cmc has… Read More

Pharmaceutical Breakthrough

Pharmaceutical and biotech companies have made huge advances recently in the fight against cancer. The Daily Mail has published a heart-warming article highlighting the huge effect that a new class of drugs called Antibody Drug Conjugates (ADCs) drugs can have on people. http://www.dailymail.co.uk/health/article-2567455/Cancer-patients-lethal-70-tumours-disappear-just-two-WEEKS-thanks-pioneering-treatment.htmlA British man suffering from a rare form of lymphoma was given only weeks to live after scans showed that… Read More

Get In Touch.


By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.